Another murine model used dual checkpoint (PD-1 and CTLA-4) blockade, causing lung inflammation with systemic T cell activation, suggesting that immunotherapy-mediated peripheral activation of T cells may be the initial immune derangement leading to CIP (135). The gene discussed is CTLA4; the disease is hereditary sensory and autonomic neuropathy.